Skip to main content
. Author manuscript; available in PMC: 2021 Sep 21.
Published in final edited form as: Prog Biomed Eng (Bristol). 2020 Feb 12;2(1):012003. doi: 10.1088/2516-1091/ab6c7d

Figure 4.

Figure 4.

(A) Tumor growth profile (Renca tumor mice model) until day 28 (14 days after injection of microspheres) for PDLLA, cisplatin, sorafenib, and cisplatin+sorafenib treated groups. (B) Tumor volumes on day 28 for all four groups. Reproduced with permission from [121].